PEDIATRIC BLOOD & CANCER, vol.47, no.7, pp.914-917, 2006 (SCI-Expanded)
Background The purpose of the study was to evaluate the plasma levels of tissue factor (TF), an angiogenic marker, and tissue factor pathway inhibitor (TFPI), an anti proliferative protein, in the childhood hemangiomas at proliferative and regressive stages.